Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

25.07
+0.13000.52%
Post-market: 25.070.00000.00%18:29 EDT
Volume:1.37M
Turnover:34.60M
Market Cap:1.41B
PE:-14.57
High:25.81
Open:24.85
Low:24.65
Close:24.94
52wk High:66.85
52wk Low:19.35
Shares:56.39M
Float Shares:53.56M
Volume Ratio:1.35
T/O Rate:2.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7207
EPS(LYR):-1.7207
ROE:-24.89%
ROA:-12.46%
PB:3.86
PE(LYR):-14.57

Loading ...

Procept Biorobotics Corp : Leerink Partners Cuts Target Price to $30 From $55

THOMSON REUTERS
·
Feb 26

Stock Track | PROCEPT BioRobotics Plunges 21.73% in Post-Market on Q4 Earnings Miss

Stock Track
·
Feb 26

Stock Track | PROCEPT BioRobotics Plunges 28.23% After-Hours on Q4 Earnings Miss

Stock Track
·
Feb 26

PROCEPT BioRobotics Q4 EPS $(0.53) Misses $(0.32) Estimate, Sales $76.383M Miss $94.137M Estimate

Benzinga
·
Feb 26

PROCEPT BioRobotics Q4 2025 U.S. procedures hit 12,200 (+69%)

Reuters
·
Feb 26

BRIEF-Procept Biorobotics Q4 Net Income USD -29.845 Million

Reuters
·
Feb 26

Procept Biorobotics Outlook FY Revenue USD 390-410 Million

THOMSON REUTERS
·
Feb 26

Procept Biorobotics Outlook FY Revenue Growth 27-33%

THOMSON REUTERS
·
Feb 26

Procept Biorobotics Corp - 2026 Revenue Guidance $390-$410 Mln

THOMSON REUTERS
·
Feb 26

PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance

GlobeNewswire
·
Feb 26

PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day

GlobeNewswire
·
Feb 24

Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Feb 24

Earning Preview: PROCEPT BioRobotics Q1 revenue is expected to increase by 40.97%, and institutional views are constructive

Earnings Agent
·
Feb 17

Procept Biorobotics präsentiert sich auf bedeutenden Gesundheitskonferenzen

Reuters
·
Feb 05

BTIG Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jan 27

Procept Biorobotics Corporation published an update to their financial calendar

Reuters
·
Jan 27

PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

GlobeNewswire
·
Jan 27

Assessing PROCEPT BioRobotics (PRCT) Valuation As Fresh Analyst Downgrade Meets Confident Long-Term Growth Views

Simply Wall St.
·
Jan 11

How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook

Simply Wall St.
·
Dec 25, 2025

PROCEPT BioRobotics Is Maintained at Buy by Truist Securities

Dow Jones
·
Dec 19, 2025